This American cryonics facility has preserved “patients” in liquid nitrogen-filled tanks until a future date when technology allows them to be thawed.

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE CONVERSATION) As with weeds in a garden, it is a challenge to fully get rid of cancer cells in the body once they arise. They have a relentless need to continuously expand, even when they are significantly cut back by therapy or surgery.
Whalen et al. couple deep learning with functional assays in chimpanzee and human cells to interrogate the neurodevelopmental enhancer potential of 2,645 human accelerated regions (HARs). Activity is dominated by cis rather than trans effects, and compensatory changes are identified as a driver of rapid HAR evolution.
Cardiovascular disease (CVD) is the #1 cause of death globally and encompasses a broad set of over a dozen disorders that compromise the function of the heart and blood vessels. The major cause of CVD by far, however, is the pathological process of (CDC, 2022). Like the accumulation of rust within pipes, involves the gradual build up of plaque within arteries which compromises the flow of blood and oxygen in the body. Strikingly, is responsible for more than 40% of all deaths worldwide, and 80% of those deaths are in individuals 65 years and older. This includes mortality from devastating pathologies that are among the leading causes of death like coronary artery disease, chronic obstructive pulmonary disorder and stroke (Pahwa, 2022).
A new test that ‘fishes’ for multiple respiratory viruses at once using single strands of DNA as ‘bait’, and gives highly accurate results in under an hour, has been developed by Cambridge researchers.
The test uses DNA ‘nanobait’ to detect the most common respiratory viruses – including influenza, rhinovirus, RSV and COVID-19 – at the same time. In comparison, PCR (polymerase chain reaction) tests, while highly specific and highly accurate, can only test for a single virus at a time and take several hours to return a result.
While many common respiratory viruses have similar symptoms, they require different treatments. By testing for multiple viruses at once, the researchers say their test will ensure patients get the right treatment quickly and could also reduce the unwarranted use of antibiotics.
HAL [Hybrid Assistive Limb] is the world’s first technology that improves, supports, enhances and regenerates the wearer’s physical functions. Made by Cyberdyne 2018.
In this video a woman in a wheelchair since childhood because of polio walks again.
Click visits the Cyberdyne company in Japan, who are manufacturing HAL (Hybrid Assisted Limb) exoskeleton’s.
Subscribe HERE http://bit.ly/1uNQEWR
Find us online at www.bbc.com/click.
Twitter: @bbcclick.
Facebook: www.facebook.com/BBCClick
It’s a hidden, lifelong process that’s tied to cancer, heart disease and dementia, but there’s plenty you can do to fix the damage In the past few years, a new buzzword has entered conversations about illness and disease. Doctors are increasingly talking about “inflammation” – a term which describes the automatic response – or flaring up – of the body when it tries to fight infections, toxins and trauma.
A lethal bird flu outbreak that has been circling the globe since 2021 peaked in Japan this week, as an agriculture ministry official said on Tuesday the country plans to cull more than 10 million chickens at risk of exposure to the virus.
Flu is a common annual illness among wild birds yet the H5N1 strain now sweeping Japan is uniquely contagious and deadly. It poses such high risk to farmed birds, such as chickens and turkeys, that a single infection on a farm condemns the entire flock to be killed. As outbreaks in Japan have reached a record high, the cull is the largest ever planned for the yearly flu season that runs from October to May.
Around the globe, record-breaking death tolls due to the virus are becoming the norm. In the US, more states than ever before have reported instances of bird flu with an all-time high of nearly 58 million poultry affected as of January 2023.
Cambridge researchers have developed a new test that “fishes” for multiple respiratory viruses at once using single strands of DNA as bait and gives highly accurate results in under an hour.
The test uses DNA “nanobait” to detect the most common respiratory viruses —including influenza, rhinovirus, RSV and COVID-19—at the same time. In comparison, PCR (polymerase chain reaction) tests, while highly specific and highly accurate, can only test for a single virus at a time and take several hours to return a result.
While many common respiratory viruses have similar symptoms, they require different treatments. By testing for multiple viruses at once, the researchers say their test will ensure patients get the right treatment quickly and could also reduce the unwarranted use of antibiotics.